1-[(2-氟苯基)甲基]吡咯-2-甲醛 | 63880-57-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-[(2-氟苯基)甲基]吡咯-2-甲醛
• 英文名称: 1-[(2-fluorophenyl)methyl]pyrrole-2-carboxaldehyde
• 英文别名: 1-(o-fluorobenzyl)pyrrole-2-carboxaldehyde；1-(2-fluorobenzyl)pyrrolo-2-carbaldehyde；1-(2-fluorobenzyl)pyrrole-2-carboxaldehyde；1-(2-Fluorobenzyl)pyrrol-2-carboxaldehyd；1-[(2-fluorophenyl)methyl]pyrrole-2-carbaldehyde
• CAS: 63880-57-9
• 化学式: C₁₂H₁₀FNO
• 分子量: 203.216
• InChiKey: WFMSAHWKWXBPRA-UHFFFAOYSA-N

物化性质

• 沸点：
  317.8±22.0 °C(Predicted)
• 密度：
  1.13±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  22
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-[(2-氟苯基)甲基]吡咯-2-甲醛 在 sodium tetrahydroborate 、 3 A molecular sieve 、 sodium hydride 、 三氯氧磷 作用下， 以 甲醇 、 异丙醇 、 苯 为溶剂， 反应 54.25h， 生成 N-methyl-5H,11H-pyrrolo<2,1-c><1,4>benzoxazepine-3-methanamine
  参考文献：
  名称：

  吡咯并[2,1- c ] [1,4]苯并x氮杂的合成。1.一种新颖的杂环系统

  摘要：

  描述了一种新的吡咯并[2,1- c ] [1,4]苯并x氮杂ring环系统（II）的亲核芳族氟化物置换环化的合成。通过Mannich反应或Vilsmeier甲酰化制备氨基烷基衍生物以提供3-甲酰基衍生物，其进一步进行了阐述。

  DOI：

  10.1002/jhet.5570220429
• 作为产物：
  描述：

  2-吡咯甲醛 、 2-氟溴苄 在 sodium hydroxide 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以100%的产率得到1-[(2-氟苯基)甲基]吡咯-2-甲醛
  参考文献：
  名称：

  6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic Acids as Dual Inhibitors of Recombinant HIV-1 Integrase and Ribonuclease H, Synthesized by a Parallel Synthesis Approach

  摘要：

  The increasing efficiency of HAART has helped to transform HIV/AIDS into a chronic disease. Still, resistance and drug drug interactions warrant the development of new anti-HIV agents. We previously discovered hit 6, active against HIV-1 replication and targeting RNase H in vitro. Because of its diketo-acid moiety, we speculated that this chemotype could serve to develop dual inhibitors of both RNase H and integrase. Here, we describe a new series of 1-benzyl-pyrrolyl diketohexenoic derivatives, 7a-y and 8a-y, synthesized following a parallel solution-phase approach. Those 50 analogues have been tested on recombinant enzymes (RNase H and integrase) and in cell-based assays. Approximately half (22) exibited inhibition of HIV replication. Compounds 7b, 7u, and 8g were the most active against the RNase H activity of reverse-transcriptase, with IC50 values of 3, 3, and 2.5 mu M, respectively. Compound 8g was also the most potent integrase inhibitor with an IC50 value of 26 nM.

  DOI：

  10.1021/jm401040b

文献信息

• Diketo Acids Derivatives as Dual Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and the Reverse Transcriptase RNase H Domain
  作者：R. Di Santo

  DOI：10.2174/092986711796504619

  日期：2011.8.1

  The HIV-1 integrase (IN) and reverse transcriptase (RT) are essential enzymes in the virus cycle. RT is crucial for the retrotranscription of the RNA viral genome, while IN is involved in the insertion in host chromosome of the proviral double strand DNA produced by RT. This enzyme has two associated functions: the RNA- and DNA-dependent DNA polymerase (RDDP and DDDP) and the ribonuclease H (RNase H). The RNase H function catalyzes the selective hydrolysis of the RNA strand of the RNA:DNA heteroduplex replication intermediate. Since the discovery that catalytic cores of both HIV-1 RNase H and IN are folded in a very similar way, have very similar active site geometries, and show the same DDE triad absolutely required for catalytic activity, some researches were devoted to study IN and RNase H dual inhibitor. Our decennial interest in design and synthesis of IN inhibitors led us to study the activity of our compounds also on RNase H activity. The results of the activities showed by pyrrolyl and quinolonyl diketo acids are reported and discussed.

  HIV-1 整合酶（IN）和逆转录酶（RT）是病毒循环中的重要酶。RT 对 RNA 病毒基因组的逆转录至关重要，而 IN 则参与将 RT 产生的前病毒双链 DNA 插入宿主染色体。这种酶有两种相关功能：RNA 和 DNA 依赖性 DNA 聚合酶（RDDP 和 DDDP）以及核糖核酸酶 H（RNase H）。RNase H 的功能是催化选择性水解 RNA:DNA 异源双工复制中间体的 RNA 链。自从发现 HIV-1 RNase H 和 IN 的催化核心以非常相似的方式折叠，具有非常相似的活性位点几何结构，并显示出催化活性绝对需要的相同 DDE 三元组之后，一些研究人员致力于 IN 和 RNase H 双抑制剂的研究。我们对 IN 抑制剂的设计和合成有着长达十年的兴趣，这促使我们研究我们的化合物对 RNase H 的活性。报告和讨论了吡咯基和醌基二酮酸的活性结果。
• Piperazionalkylpyrrolobenzoxazalkanes
  申请人：American Hoechst Corporation

  公开号：US04053599A1

  公开（公告）日：1977-10-11

  Novel piperazinoalkylpyrrolobenzoxazalkanes, physiologically tolerable acid addition salts thereof and a method of preparing same are described. These compounds are useful as antihypertensive agents.

  本发明涉及一种新型哌嗪基烷基吡咯苯氧唑烷，其生理上可耐受的酸盐及其制备方法。这些化合物可用作降压剂。
• 11-Substituted 5H,11H-pyrrolo[2,1-c][1,4]benzoxazepines, a process for their preparation and their use in medicaments
  申请人：HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED

  公开号：EP0144729A1

  公开（公告）日：1985-06-19

  There are described to novel 11-substituted 5H,11H-pyrrolo[2,1-c] [1,4]benzoxazepines of the general formula where m and n are each independently, 0,1 or 2 and m + n is 1or 2, X and Y are each independently hydrogen, loweralkyl or halogen, and R is hydrogen, cyano, unsubstituted loweralkyl, or substituted loweralkyl having one to three substituents each of which being independently cyano, hydroxy, cyclohexyl, furyl, k being 1, 2 or 3, W being each independently hydrogen, halogen, hydroxy, loweralkyl, trifluoromethyl, loweralkoxy, nitro, amino, diloweralkylamino, phenoxy, or benzyloxy, and Z being hydrogen, loweralkyl or halogen, which are useful as antipsychotic and analgesic agents; novel intermediate compounds therefor; and methods of synthesizing the foregoing compounds.

  描述了通式为 11-取代 5H，11H-吡咯并[2,1-c] [1,4]苯并噁唑杂卓的新化合物 其中m和n各自独立地为0、1或2，m+n为1或2，X和Y各自独立地为氢、低级烷基或卤素，R为氢、氰基、未取代的低级烷基或取代的低级烷基、 未取代的低级烷基，或具有 1 至 3 个取代基的取代低级烷基，每个取代基独立为氰基、羟基、环己基、呋喃基、 k是1、2或3，W各自独立地是氢、卤素、羟基、低级烷基、三氟甲基、低级烷氧基、硝基、氨基、稀低级烷基氨基、苯氧基或苄氧基，Z是氢、低级烷基或卤素，这些化合物可用作抗精神病药和镇痛药；其新型中间体化合物；以及合成上述化合物的方法。
• Intermediates for the preparation of 11-substituted 5H, 11H-pyrrolo [2,1-c][1,4] benzoxazepines, and a method for their preparation
  申请人：HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED

  公开号：EP0258612A1

  公开（公告）日：1988-03-09

  This invention relates to novel compounds of the formula I wherein m and n are each independently 0,1 or 2 and m + n is 1 or 2, X and Y are each independently hydrogen, loweralkyl or halogen and Rs is methyl or benzyl, which are useful as intermediates for the preparation of 11-substituted 5H,11H-pyrrolo [2,1-c] [1,4] benzoxazepines of the formula II The compounds of formula II exhibit antipsychotic and ana-Igesic activities and can, therefore, be used as medicaments.

  本发明涉及式 I 的新型化合物，其中 m 和 n 各自独立地为 0、1 或 2，m + n 为 1 或 2，X 和 Y 各自独立地为氢、低级烷基或卤素，Rs 为甲基或苄基，这些化合物可用作制备式 II 的 11-取代的 5H、11H-吡咯并[2,1-c] [1,4] 苯并氧氮杂卓的中间体。
• Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activity
  作者：R. Di Santo、R. Costi、M. Artico、R. Ragno、G. Greco、E. Novellino、C. Marchand、Y. Pommier

  DOI：10.1016/j.farmac.2005.03.008

  日期：2005.5

  Highly active anti-retroviral therapy (HAART) using reverse transcriptase (RT) and protease (PR) inhibitors and, more recently, inhibitors of the fusion is currently the best clinical approach in combating acquired immunodeficiency syndrome (AIDS), caused by infection from human immunodeficiency virus type 1 (HIV-1). However, this therapy does not completely eradicate the virus, so that resistant strains easily emerge. The above problem calls urgently for research on inhibitors of further viral targets such as integrase (IN), the third enzyme produced by HIV. Recently, our research group was engaged in studies on conformationally restrained cinnamoyl compounds related to curcumin as anti-IN agents. Compounds containing both a 3,4,5-trihydroxyphenyl group and a carboxylic acid function were potent IN inhibitors active against viral replication. More recently, a promising new class of inhibitors synthesized by Merck Company has emerged, which contain aryldiketoacid (ADK) functionality. The ADKs selectively inhibited the stand transfer (ST) step of integration and were proven to be effective IN inhibitors in vivo. Our interest in the field of IN inhibitors led us to design pyrrole and indole derivatives containing both a cinnamoyl moiety and a diketoacid group. A number of the cited derivatives were proven potent IN inhibitors, which selectively inhibited the ST step at submicromolar concentrations and were effective against virus replication in HIV-1 infected cells.